Pilot study of pharmacological treatment for frontotemporal dementia: Effect of Yokukansan on behavioral symptoms

Psychiatry and Clinical Neurosciences

Volumn 64, Issue 2, 2010, Pages 207-210

  Kimura, Takemi ^a   Hayashida, Hideki ^b   Furukawa, Hitomi ^b   Takamatsu, Junichi ^a  

^a Kikuchi National Hospital Division of Clinical Research   (Japan)

^b Kumamoto Yushin Hospital   (Japan)

Author keywords

Antipsychotic agents; Behavioral symptoms; Frontotemporal dementia; Neuropsychiatric inventory; Yokukansan

Indexed keywords

HERBACEOUS AGENT; UNCLASSIFIED DRUG; YOKUKANSAN;

AGED; ANOREXIA; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FRONTOTEMPORAL DEMENTIA; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOKALEMIA; MALE; MINI MENTAL STATE EXAMINATION; NAUSEA; NEUROPSYCHIATRIC INVENTORY; PILOT STUDY; PSYCHOLOGICAL RATING SCALE; STEREOTYPY RATING INVENTORY;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DRUGS, CHINESE HERBAL; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PATIENT SELECTION; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 77949991508     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2010.02072.x     Document Type: Article

References (14)

1. Neary D, Snowden JS, Gustafson L et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998 51 : 1546 1554.
2. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005 294 : 1934 1943.
3. Iwasaki K, Satoh-Nakagawa T, Maruyama M et al. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J. Clin. Psychiatry 2005 66 : 248 252.
4. Kimura T, Hayashida H, Furukawa H, Miyauchi D. Five cases of frontotemporal dementia with behavioral symptoms improved by Yokukansan. Psychogeriatrics 2009 9 : 38 43.
5. Hirono N, Mori E, Ikejiri Y et al. Japanese version of the Neuropsychiatric Inventory: A scoring system for neuropsychiatric disturbances in dementia patients. Brain Nerve 1997 49 : 266 271 (in Japanese).
6. Shigenobu K, Ikeda M, Fukuhara R et al. The stereotypy rating inventory for frontotemporal lobar degeneration. Psychiatry Res. 2002 110 : 175 187.
7. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994 44 : 2308 2314.
8. Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: An open-label study. J. Geriatr. Psychiatry Neurol. 2008 9 : 1 6.
9. Shigenobu K, Ikeda M, Fukuhara R et al. Reducing the burden of care for Alzheimer's disease through the amelioration of 'delusions of theft' by drug therapy. Int. J. Geriatr. Psychiatry 2002 17 : 211 217.
10. Francis PT, Holmes C, Webster MT, Stratmann GC, Procter AW, Bowen DM. Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia 1993 4 : 172 177.
11. Proctor AW, Qurne M, Francis PT. Neurochemical features of frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 1999 10 (Suppl. 1 80 84.
12. Sparks DL, Markesbery WR. Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch. Neurol. 1991 48 : 796 799.
13. Ishibashi A, Egashira N, Mishima K, Iwasaki K, Fujiwara M. Study on the central action of Yoku-kan-san. Yakugaku Zasshi 2006 126 (Suppl. 2 82 84 (in Japanese).
14. Takeda A, Itoh H, Tamano H, Yuzuriha M, Oku N. Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats. Nutr. Neurosci. 2008 11 : 41 46.